Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Norman Wolmark, MD
Woman and Man Max 99 years
Norman Wolmark, MD
Update Il y a 4 ans
Combination Chemotherapy Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
RATIONALE: Drugs used in chemotherapy work in different ways to kill tumor cells or stop them from growing. Giving combination chemotherapy before surgery may make the tumor smaller and re...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman Max 99 years
Norman Wolmark, MD
Update Il y a 4 ans
A Study of AC Followed by a Combination of Paclitaxel Plus Trastuzumab or Lapatinib or Both Given Before Surgery to Patients With Operable HER2 Positive Invasive Breast Cancer
The primary purpose of this study is to determine whether breast cancer tumors respond (as measured by pathologic complete response: the absence of microscopic evidence of invasive tumor c...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman Max 99 years
Norman Wolmark, MD
Update Il y a 4 ans
Phase II Randomized Trial Evaluating Neoadjuvant Therapy With Neratinib and/or Trastuzumab Followed by Postoperative Trastuzumab in Women With Locally Advanced HER2-positive Breast Cancer
FB-7 is a Phase II, multi-center randomized study of neratinib in combination with weekly paclitaxel with or without trastuzumab followed by doxorubicin and cyclophosphamide (AC) as neoadj...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman Max 99 years
Norman Wolmark, MD
Update Il y a 4 ans
Surgery to Remove Sentinel Lymph Nodes With or Without Removing Lymph Nodes in the Armpit in Treating Women With Breast Cancer
RATIONALE: Removing the sentinel lymph nodes and examining them under a microscope may help plan more effective surgery for breast cancer. It is not yet known if surgery to remove the sent...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman Max 99 years
Norman Wolmark, MD
Update Il y a 4 ans
Exemestane in Treating Postmenopausal Women With Resected Stage I, Stage II, or Stage IIIA Breast Cancer Who Have Completed 5 Years of Tamoxifen
RATIONALE: Estrogen can stimulate the growth of breast cancer cells. Hormone therapy using exemestane may fight breast cancer by reducing the production of estrogen by the tumor cells. It ...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman Max 99 years
Norman Wolmark, MD
Update Il y a 4 ans
Comparison of Neoadjuvant Chemotherapy With Weekly Paclitaxel or Eribulin Followed by A/C in Women With Locally Advanced HER2-Negative Breast Cancer
NSABP FB-9 is a Phase II, multi-center, randomized study of eribulin or weekly paclitaxel followed by doxorubicin and cyclophosphamide (AC) as neoadjuvant therapy for women with HER2-negat...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman Max 99 years
Norman Wolmark, MD
Update Il y a 5 ans
Combination of Weekly Paclitaxel With Neratinib and Trastuzumab in Women With Metastatic HER2-positive Breast Cancer
The FB-8 study is designed as an open label, single arm, Phase I dose-escalation study evaluating the combination of weekly paclitaxel with neratinib and trastuzumab in women with metastat...
Country
United States
organs
None
Specialty
None
Closed trial
More information
Woman Max 99 years
Norman Wolmark, MD
Update Il y a 4 ans
BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab
The trial will determine the value of adding bevacizumab to chemotherapy plus trastuzumab in patients with resected node-positive or high risk node-negative, HER2-positive breast cancer.
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman Max 99 years
Norman Wolmark, MD
Update Il y a 4 ans
Studying Biological Markers of Fatigue in Women With Residual Invasive Breast Cancer Enrolled on Clinical Trial NSABP-B-45
RATIONALE: Studying samples of blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to fatigue. ...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Norman Wolmark, MD
Update Il y a 4 ans
Study of Panitumumab Given First With Capecitabine and Oxaliplatin (CAPOX) and Then With Capecitabine and Radiation of the Pelvis for Treatment of Patients With Rectal Cancers That May or May Not Have Spread Beyond the Rectum
Panitumumab is a monoclonal antibody. It works by attaching to a protein called epidermal growth factor receptor found on normal and cancer cells. When panitumumab attaches, it blocks anot...
Country
None
organs
None
Specialty
None
Closed trial
More information
Previous
1
2
3
4
5
Next